Cargando…
Assessing a biomarker’s ability to reduce invasive procedures in patients with benign lung nodules: Results from the ORACLE study
A blood-based integrated classifier (IC) has been clinically validated to improve accuracy in assessing probability of cancer risk (pCA) for pulmonary nodules (PN). This study evaluated the clinical utility of this biomarker for its ability to reduce invasive procedures in patients with pre-test pCA...
Autores principales: | Pritchett, Michael A., Sigal, Barry, Bowling, Mark R., Kurman, Jonathan S., Pitcher, Trevor, Springmeyer, Steven C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335667/ https://www.ncbi.nlm.nih.gov/pubmed/37432960 http://dx.doi.org/10.1371/journal.pone.0287409 |
Ejemplares similares
-
Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial
por: Silvestri, Gerard A., et al.
Publicado: (2018) -
Managing Lung Nodules Using Telemedicine and Molecular Biomarkers During the COVID-19 Pandemic
por: Springmeyer, Steven C., et al.
Publicado: (2020) -
An integrated risk predictor for pulmonary nodules
por: Kearney, Paul, et al.
Publicado: (2017) -
Programming Oracle triggers and stored procedures
por: Owens, Kevin
Publicado: (2004) -
Oracle essentials: Oracle9i, Oracle8i, and Oracle8
por: Greenwald, Rick, et al.
Publicado: (2001)